Alcon Inc. (ALC)
Alcon Inc. (ALC) is a healthcare company (medical instruments & supplies) based in Switzerland. The share price is $74.18, up 0.73% on the day, which values the company at $35.64B. Price as of 17 Nov 2026, 17:14 UTC, from Yahoo Finance.
Key facts
- Share price
- $74.18+0.73% today
- Market value
- $35.64B
- P/E ratio
- 54.1×last 12 months
- Forward P/E
- 19.0×
- Dividend yield
- 0.48%
- Funk Score
- 56/100
- Against its own history
- Below its usual priceusual price $82.45
- 200-week average
- $80.588% below
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Alcon Inc. in more detail
ALC trades at 54.1× its last twelve months' earnings, 19.0× next year's expected earnings, 3.2× sales. Measured against its own history, the price is 10% below what its usual multiples would imply ($82.45) — below its usual price. It sits 8% below its 200-week average of $80.58.
Its Funk Score is 56 out of 100 (financial strength 5.3, profitability 4.5, growth 7.0, value 5.6, each out of 10).
In its favour: Five straight years of revenue growth. Worth checking: Low return on invested capital.
4 of the superinvestors tracked here hold ALC, including Nicolai Tangen (founder) (17.7% of the portfolio), Howard Gleicher (1.3% of the portfolio), Sarah Ketterer (0.0% of the portfolio).
Superinvestors holding ALC
4 of the investors tracked here report a position in their latest 13F filing.
- Nicolai Tangen (founder) AKO Capital17.7% of portfolio · $557.7M · trimmed · Q3 2026
- Howard Gleicher Aristotle Capital Management1.26% of portfolio · $552.7M · trimmed · Q3 2026
- Sarah Ketterer Causeway Capital Management0.02% of portfolio · $2.1M · new · Q3 2026
- Lee Ainslie Maverick Capital0.02% of portfolio · $2.2M · added · Q2 2026
Health Care companies of similar size
- Revolution MedicinesRVMD
- Royalty PharmaRPRX
- BiogenBIIB
- GE HealthCare TechnologiesGEHC
- Mettler-Toledo InternationalMTD
- CenteneCNC
- GenmabGMAB
- IlluminaILMN
- ResMedRMD
- ZoetisZTS
- Labcorp HoldingsLH
- DexComDXCM
Side by side:ALC vs MTD (Alcon Inc. vs Mettler-Toledo International)ALC vs GEHC (Alcon Inc. vs GE HealthCare Technologies)ALC vs BIIB (Alcon Inc. vs Biogen)ALC vs CNC (Alcon Inc. vs Centene)ALC vs GMAB (Alcon Inc. vs Genmab)
All health care companies by market valueLargest companies in SwitzerlandAll stocks A–Z
Alcon Inc. (ALC): questions and answers
What is ALC's P/E ratio?
Alcon Inc. trades at 54.1× its last twelve months' earnings and 19.0× next year's expected earnings. At its fiscal year-ends over the past 4 years the P/E ranged from 39.8× to 100.8×, with a median of 40.6×.
What is ALC's PEG ratio?
Alcon Inc.'s PEG ratio is 1.31 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Alcon Inc.'s market cap?
Alcon Inc. is valued at $35.64B at a share price of $74.18.
Is ALC overvalued or undervalued?
Against its own history, ALC is below its usual price: the price is 10% below the $82.45 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is ALC above its 200-week moving average?
No. ALC is 7.9% below its 200-week average of $80.58. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Alcon Inc. growing?
Over the last three fiscal years Alcon Inc.'s revenue grew 6.1% a year and its earnings per share 42.8% a year.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Alcon Inc. (ALC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ALC
Underlying data: Yahoo Finance; company filings with the SEC.